Objectives: To investigate the reliability of cefoxitin and oxacillin for the detection of mecC-positive Staphylococcus aureus.
Introduction
The first homologue of the mecA gene identified in Staphylococcus aureus has been described recently from human and animal sources. 1, 2 Provisionally named mecA LGA251 following its identification in the discovery strain LGA251, the gene has now been designated mecC. 3 The mecC gene has only 69% nucleotide sequence identity to the mecA prototype of N315, and PBP2a var encoded by mecC shows just 63% homology to the PBP2a encoded by mecA.
1 From a primary diagnostic perspective, it is important to note that mecC-positive strains will fail to be detected by current mecA-based PCR assays or the PBP2a agglutination test performed on primary cultures. 4 This investigation was undertaken to examine the ability of cefoxitin or oxacillin to detect mecC-positive methicillin-resistant S. aureus (MRSA) phenotypically using: agar dilution (AD) on IsoSensitest agar, Columbia agar (+2% NaCl in the case of oxacillin) and Mueller-Hinton (MH) agar (+2% NaCl in the case of oxacillin); broth microdilution (BMD) in MH broth (+2% NaCl in the case of oxacillin); Etest on MH agar (+2% NaCl in the case of oxacillin); and disc diffusion (DD). MH agar is recommended by EUCAST and CLSI, 5 -7 whereas Columbia agar +2% NaCl (for oxacillin MIC) and IsoSensitest agar (for oxacillin and cefoxitin DD) are recommended by the BSAC. 8 Furthermore, because of differences in initial test results, DD was performed using three different brands of MH in parallel.
Materials and methods
A total of 62 mecC-positive S. aureus isolates from a range of human and animal sources, including the whole-genome sequenced strain LGA251 1 The isolates belonged to 13 different spa types (t742, t843, t978, t1535, t6220, t6292, t6293, t6386, t7485, t7735, t7945, t7946 and t7947), which could be assigned to either CC130 (n ¼56), CC425 (n¼4) or CC1943 (n¼2) (where CC stands for clonal complex). S. aureus ATCC 29213 was included for quality control purposes.
MICs of cefoxitin and oxacillin were determined using AD with IsoSensitest, Columbia and MH agars and an inoculum of 1×10 4 cfu per spot. BMD was performed as described by EUCAST 5 using MH BBL II broth [Becton Dickinson (BD), Heidelberg, Germany] using a final inoculum of 5×10 5 cfu/mL. Etests (bioMérieux, Marcy l'Étoile, France) were performed on MH BBLII (BD). For BMD, AD and Etest methods, MH and Columbia media were supplemented with 2% NaCl for oxacillin testing. DD was performed as described by the BSAC, using Iso-Sensitest agar, and by EUCAST, using three different brands of MH agar [Oxoid, Basingstoke, UK; BD (BBLII) and bioMérieux]. 5, 8 MH plates from bioMérieux were factory made, whereas powdered MH medium from BD and Oxoid was used to prepare plates at the participating laboratories. Cefoxitin (30 mg) and oxacillin (1 mg) discs were obtained from Oxoid. The following breakpoints were used: (i) BSAC: cefoxitin MIC resistant (R) .4 mg/L, DD R≤ 21 mm and susceptible (S) ≥22 mm (Iso-Sensitest); oxacillin MIC R. 2 mg/L (MH+2% NaCl and Columbia+2% NaCl); 5 (ii) CLSI: cefoxitin MIC R ≥8 mg/L and S≤ 4 mg/L, DD R≤ 21 mm and S≥22 mm (MH); oxacillin MIC R≥ 4 mg/L and S≤2 mg/L (MH+2% NaCl); 9 and (iii) EUCAST: cefoxitin DD R,22 mm and S≥22 mm (MH). 10 On initial testing, the poor performance of MH agar from bioMérieux for the detection of mecC-MRSA compared with MH agar from Oxoid and BD was noted. DD was thus repeated on agar plates supplied by bioMérieux and plates prepared using BBLII powder (BD); three discs were applied to each agar plate (triplicate testing). The discs used were from Oxoid (different lots) and one batch of discs from BD. AD was undertaken at the Public Health England Reference Laboratory; all other methods were undertaken at the Statens Serum Institut, Denmark.
Results
The results for cefoxitin and oxacillin for the different MIC methodologies are shown in Table 1 . For cefoxitin on MH media, all isolates were resistant by BMD and AD, whilst by Etest, one isolate had an MIC in the susceptible range (1 mg/L). For AD using Iso-Sensitest agar, one isolate was falsely susceptible (4 mg/L). With respect to oxacillin testing, the results were more variable: on AD using Columbia+2% NaCl all mecC-positive isolates were detected, whereas on MH+2% NaCl media, six/zero (two different laboratories), four and five isolates were (falsely) susceptible by AD, BMD and Etest, respectively.
When tested by DD using cefoxitin on Iso-Sensitest agar, 18 (29%) isolates were falsely susceptible ( Table 2) . Using MH agar, considerable differences were observed between the three different brands. Considerably poorer performance (i.e. false susceptibility) was observed for both cefoxitin and oxacillin using MH agar from bioMérieux compared with that from BD and Oxoid (Tables 2 and 3 ). For cefoxitin, all isolates were resistant using MH agar from BD and Oxoid, whereas for MH agar from bioMérieux, 16 (26%) were falsely susceptible. On repeat testing, similar results were observed for bioMérieux agar, with false susceptibility rates of 39% -47% (Table 2 ). For oxacillin, 6%, 15% and 60% of isolates were falsely susceptible using agar from Oxoid, BD and bioMérieux, respectively ( Table 3 ). The quality control organism (S. aureus ATCC 29213) had values within range for all tests (regardless of brand of agar) except for cefoxitin AD, where an MIC of 8 mg/L was obtained (quality control MIC and DD ranges for S. aureus ATCC 29213: 1 -4 mg/L for cefoxitin on MH, 24-30 mm for cefoxitin DD on MH and 24-29 mm for cefoxitin DD on Iso-Sensitest agar). Falsely susceptible results are in bold.
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Discussion
As previously reported for mecA-MRSA, 11 this study shows that cefoxitin is also a reliable agent for the detection of mecC-positive MRSA when tested on MH agar as recommended by EUCAST. 5 By contrast, it is important to note that almost one in three isolates appeared susceptible by DD using Iso-Sensitest agar as recommended by the BSAC; 8 similarly, one isolate appeared susceptible by AD using Iso-Sensitest agar.
Oxacillin was only reliable for the detection of mecC-MRSA if MICs were determined using AD with Columbia agar containing 2% NaCl. The lower ability of oxacillin to detect mecC-MRSA isolates is most likely a result of a 4-fold higher affinity of the mecC-encoded PBP2a var for oxacillin (i.e. lower MICs) compared with cefoxitin. 12 The study further showed that MH agar from bioMérieux performed with considerably lower sensitivity than MH agar from Oxoid or BD. bioMérieux was contacted and confirmed the lower sensitivity of that product for the group of MRSA. In response to this, bioMérieux has recently launched a modified MH plate, MHE, which in initial investigations performs well for detection of mecC-positive isolates by DD using cefoxitin (Gilles Zambardi, bioMérieux, personal communication).
This study confirmed that the detection of MRSA using cefoxitin has better performance on MH than Iso-Sensitest media, but that there may be substantial differences in the performance of different brands of MH agar. It is well known that the phenotypic detection of MRSA is method dependent and that it is important for the individual laboratory to use a known mecC-positive isolate as a control. This ensures that the number of false results, with their inevitable impact on infection control and patient management, are reduced to a minimum.
In conclusion, cefoxitin testing using MH media following the methodology outlined by EUCAST reliably detects resistance in mecC-positive MRSA in media supplied by BD and Oxoid, whereas media from bioMérieux perform less well. The use of Iso-Sensitest media as recommended by the BSAC may lead to false susceptibility, which may have clinical consequences and lead to suboptimal infection control measures.
